Comprehensive circulating microRNA profile as a supersensitive biomarker for early-stage lung cancer screening

Masayasu Inagaki; Makoto Uchiyama; Kanae Yoshikawa-Kawabe; Masafumi Ito; Hideki Murakami; Masaharu Gunji; Makoto Minoshima; Takashi Kohnoh; Ryota Ito; Yuta Kodama; Mari Tanaka-Sakai; Atsushi Nakase; Nozomi Goto; Yusuke Tsushima; Shoich Mori; Masahiro Kozuka; Ryo Otomo; Mitsuharu Hirai; Masahiko Fujino; Toshihiko Yokoyama

doi:10.1007/s00432-023-04728-9

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

The miRNA-based diagnostic model showed a high sensitivity for lung cancer, including early-stage disease. Our study provides the experimental evidence that serum comprehensive miRNA profile can be a highly sensitive blood biomarker for early-stage lung cancer.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Inagaki et al. (2023) studied this question.

synapsesocial.com/papers/69da21a51e2c7d7b4fa3bf83 https://doi.org/10.1007/s00432-023-04728-9

View Full Paper

Ask AI

Bookmark

Share

Comprehensive circulating microRNA profile as a supersensitive biomarker for early-stage lung cancer screening

Ask about this paper

Abstract

Discussion

Cite This Study

Comprehensive circulating microRNA profile as a supersensitive biomarker for early-stage lung cancer screening

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading